Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 14/20 | 0.51 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.42 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.42 |
| ▸ | CFTR | P13569 | 1/20 | 0.42 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | CTRC | Q99895 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30674005 | 1.00 | CYP19A1 (0.51) | CYP19A1DDB1CRBNCFTRGOPC | |
| SCHEMBL577209 | 0.77 | CYP19A1 (0.56) | CYP19A1CFTRGOPCTSHRCTRC | |
| SCHEMBL3142533 | 0.77 | CYP19A1 (0.47) | CYP19A1CFTRGOPCTSHR | |
| SCHEMBL8061349 | 0.71 | CYP19A1 (0.48) | CYP19A1CFTRGOPCTSHR | |
| SCHEMBL6045102 | 0.70 | BRD4 (0.36) | CYP19A1CTRC | |
| SCHEMBL21594818 | 0.69 | DDB1 (0.51) | CYP19A1DDB1CRBNCFTRGOPC | |
| SCHEMBL5431297 | 0.69 | TSHR (0.47) | CYP19A1TSHR | |
| Isoflavanone SCHEMBL72983 | 0.68 | CYP19A1 (1.00) | CYP19A1 | |
| SCHEMBL2700586 | 0.68 | CYP19A1 (0.58) | CYP19A1 | |
| Isoflavanone SCHEMBL15883785 | 0.68 | CYP19A1 (1.00) | CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210317099-A1 | SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS | PURDUE RESEARCH FOUNDATION (US) | 2021-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210317099-A1 | SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS | MIF, LTA, MGAM | CYP19A1 2911/4885DDB1 3766/4885CRBN 2682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.